Skip to main content

View full-text article in PMC

. 2009 Nov 16;30(12):1709–1716. doi: 10.1038/aps.2009.157

Table 4. The content of ergosta-8,14,22-trienol and ignosterol as well as the ratio of ergosta-8,14,22-trienol to ignosterol in BWP17 strain treated with different concentrations of 10b.

Concentrations of 10b (μg·mL⁻¹)	Content (μg)
Concentrations of 10b (μg·mL⁻¹)	Ergosta-8,14,22-trienol	Ignostrol	Ratio^a
0.025	156.23±15.71	20.47±7.76	7.63
0.05	152.43±4.17	50.65±7.70	3.01
0.1	95.36±13.06	54.74±5.93	1.74
0.2	66.40±12.06	53.67±10.69	1.24
0.4	73.92±6.95	75.04±9.70	0.99
0.8	65.39±14.80	85.77±14.63	0.76

^aThe ratio of Ergosta-8,14,22-trienol to Ignosterol.